Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Ashendel

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Princess Takamatsu Symposia|January 1, 1983
Observations on the mechanism of skin tumor promotion by phorbol estersR K Boutwell, M Takigawa, A K Verma, et al.
Cancer Research|November 15, 1988
Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogeneC M Weyman, E J Taparowsky, M Wolfson, et al.
The Journal of Biological Chemistry|November 29, 1996
Activation of T cell Raf-1 at mitosis requires the protein-tyrosine kinase LckN I Pathan, C L Ashendel, R L Geahlen, et al.
Cancer Research|July 1, 1983
Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasoneA K Verma, C T Garcia, C L Ashendel, et al.
Biochimica Et Biophysica Acta|September 4, 1989
Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cellsW C Hooper, R T Abraham, C L Ashendel, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Novel protein kinase C inhibitors: synthesis and PKC inhibition of beta-substituted polythiophene derivativesW C Xu, Q Zhou, C L Ashendel, et al.
The Journal of Cell Biology|August 1, 1991
Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase CT B Vaidya, C M Weyman, D Teegarden, et al.
Biochemistry|September 7, 1993
Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lckM J Nadler, M L Harrison, C L Ashendel, et al.
In Vivo (Athens, Greece)|March 1, 1996
Oncogene signal transduction inhibitors from medicinal plantsC J Chang, C L Ashendel, R L Geahlen, et al.
Anti-Cancer Drug Design|August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activityS R Hill, R Bonjouklian, G Powis, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Princess Takamatsu Symposia|January 1, 1983
Observations on the mechanism of skin tumor promotion by phorbol estersR K Boutwell, M Takigawa, A K Verma, et al.
Cancer Research|November 15, 1988
Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogeneC M Weyman, E J Taparowsky, M Wolfson, et al.
The Journal of Biological Chemistry|November 29, 1996
Activation of T cell Raf-1 at mitosis requires the protein-tyrosine kinase LckN I Pathan, C L Ashendel, R L Geahlen, et al.
Cancer Research|July 1, 1983
Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasoneA K Verma, C T Garcia, C L Ashendel, et al.
Biochimica Et Biophysica Acta|September 4, 1989
Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cellsW C Hooper, R T Abraham, C L Ashendel, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 1999
Novel protein kinase C inhibitors: synthesis and PKC inhibition of beta-substituted polythiophene derivativesW C Xu, Q Zhou, C L Ashendel, et al.
The Journal of Cell Biology|August 1, 1991
Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase CT B Vaidya, C M Weyman, D Teegarden, et al.
Biochemistry|September 7, 1993
Treatment of T cells with 2-hydroxymyristic acid inhibits the myristoylation and alters the stability of p56lckM J Nadler, M L Harrison, C L Ashendel, et al.
In Vivo (Athens, Greece)|March 1, 1996
Oncogene signal transduction inhibitors from medicinal plantsC J Chang, C L Ashendel, R L Geahlen, et al.
Anti-Cancer Drug Design|August 1, 1994
A multisample assay for inhibitors of phosphatidylinositol phospholipase C: identification of naturally occurring peptide inhibitors with antiproliferative activityS R Hill, R Bonjouklian, G Powis, et al.
Pageof 5